Meghan McIntosh Heberton, MD
Department of Dermatology, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Dermatology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2013 | University of Texas Medical School, Houston, TX, USA, MD, Doctor of Medicine |
| 2009 | University of Texas, Austin, Austin, TX, USA, BA, Degree in Plan II |
Postgraduate Training
| 2016-2019 | Clinical Residency, Dermatology, Barnes Jewish Hospital/SLCH Consortium, St. Louis, MO |
| 2013-2016 | Clinical Residency, Internal Medicine, Barnes Jewish Hospital Washington University of St. Louis, St. Louis, MO |
Board Certifications
| 2019 | American Board of Dermatology |
| 2016 | The American Board of Internal Medicine |
Selected Publications
Peer-Reviewed Articles
- Hanania HL, Pacha O, Heberton M, Patel AB. Surgical Intervention for Paronychia Induced by Targeted Anticancer Therapies. Dermatol Surg 47(6):775-779, 2021. PMID: 34029250.
- McNally MA, Vangipuram R, Campbell MT, Nagarajan P, Patel AB, Curry JL, Heberton M. Paraneoplastic pemphigus manifesting in a patient treated with pembrolizumab for urothelial carcinoma. JAAD Case Rep 10:82-84, 2021. e-Pub 2021. PMID: 33778141.
- Heberton MM, Tripathi S, Slade M, Trinkaus K, Romee R, Anadkat M. Cutaneous graft-versus-host disease incidence is similar in haploidentical and matched unrelated hematopoietic transplant recipients: A retrospective cohort study. J Am Acad Dermatol S0190-9622(19):32990-1, 2020. e-Pub 2019. PMID: 31689447.
- Duke TC, Nair R, Torres-Cabala C, Amaria RN, Keiser E, Miranda R, Iyer SP, Heberton M. Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment. JAAD Case Rep 6(12):1264-1267, 2020. e-Pub 2020. PMID: 33294560.
- Heberton M, Nieman E, Jones H. A case of unilateral extremity swelling. JAAD Case Rep 5(8):746-747, 2019. e-Pub 2019. PMID: 31440574.
- Ferguson I, Heberton M, Compton L, Keller J, Cornelius L. Disseminated blastomycosis in a patient on pembrolizumab for metastatic melanoma. JAAD Case Rep 5(7):580-581, 2019. e-Pub 2019. PMID: 31312706.
- Heberton M, Azher T, Council ML, Khanna S. Metastatic Cutaneous Melanoma Presenting With Melanoma-Associated Retinopathy. Dermatol Surg 45(4):606-607, 2019. PMID: 30893173.
- Esquenazi Y, Savitz SI, El Khoury R, McIntosh MA, Grotta JC, Tandon N. Decompressive hemicraniectomy with or without clot evacuation for large spontaneous supratentorial intracerebral hemorrhages. Clin Neurol Neurosurg 128:117-22, 2015. e-Pub 2014. PMID: 25496934.
- Seervai RNH, Cho WC, Chu EY, Marques-Piubelli ML, Ledesma DA, Richards K, Heberton MM, Nelson KC, Nagarajan P, Torres-Cabala CA, Prieto VG, Curry JL. Diverse Landscape Of Dermatologic Toxicities From Small Molecule Inhibitor Cancer Therapy. J Cutan Pathol. e-Pub 2021. PMID: 34622477.
- Lo JJ, Heberton MM, Pacha O, Huen AO, Patel AB. Biologic therapies for checkpoint inhibitor-induced cutaneous toxicities: a single-institution study of 17 consecutively treated patients. Support Care Cancer. e-Pub 2021. PMID: 34519869.
- Robinson MA, Patel AB, Wilmas KM, Thomas V, Heberton M. Cutaneous Surgery Outcomes in Patients on Epidermal Growth Factor Receptor Inhibitors. Dermatol Surg. e-Pub 2021. PMID: 34417386.
Book Chapters
- Heberton M, Anadkat M. Biologics: Melanoma and BCC. In: Handbook of Dermatology Treatments. 1. JP Medical Ltd, 80-84, 2017.
Grant & Contract Support
| Title: | Mentors in Medicine |
| Funding Source: | Washington University, St. Louis |
| Role: | Investigator |